PlainRecordsLiraglutide Injection
Also listed by FDA as Saxenda, Victoza
On FDA's list as current shortage and to be discontinued: 11 packages from 4 companies. Last updated by FDA Oct. 14, 2026. Data from openFDA as of Nov. 12, 2026; FDA's own database can be newer. Not medical advice: ask your pharmacist or doctor before changing or stopping a medicine.
9 packages on FDA's current shortage list, none listed as unavailable; 3 limited, 6 available.
Reason FDA gives most often: “Delay in shipping of the drug” (2 of 9). Check with your pharmacy: FDA's list is national.Current shortage (9)
● available · ◐ limited · ○ unavailable
| Strength | Companies and FDA's availability |
|---|---|
| 6 mg/mL | ● Hikma Pharmaceuticals USA, Inc.×2, available● Meitheal Pharmaceuticals, Inc.×2, available● Novo Nordisk, Inc.×2, available◐ Novo Nordisk, Inc.×3, limited |
Each chip is a company as FDA names it, marked with FDA's availability value for its packages of that strength (×N: N packages; point at a chip for FDA's package texts). Strengths are read from FDA's package text, one row an amount ("10 mg/1 mL" and "50 mg/5 mL (10 mg/mL)" are one row, 10 mg/mL), in the unit FDA wrote; where FDA gives only an amount per volume, the amount per mL is worked out ("5 g/100 mL" is 50 mg/mL); the package sizes are listed under each strength.
By company: availability, FDA's notes and contact
Novo Nordisk, Inc.
5 packages: 2 available · 3 limited · contact 833-493-4689
Reason “Delay in shipping of the drug”
Reason “Discontinuation of the manufacture of the drug”
FDA's note “Distributed by Teva”
FDA's note “Estimated shortage duration: TBD”
FDA's note “Product will be available until discontinuation in January 2027”
Hikma Pharmaceuticals USA, Inc.
2 packages: 2 available · contact 800-631-2174
Meitheal Pharmaceuticals, Inc.
2 packages: 2 available · contact 844-824-8426
To be discontinued (2)
- Discontinued Aug. 25, 2026Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)Novo Nordisk, Inc.
- Discontinued May 14, 2026Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46)Teva Pharmaceuticals USA, Inc.
Every entry as FDA lists it (11)
Current shortage (9)
Hikma Pharmaceuticals USA, Inc.
Contact: 800-631-2174
- AvailableLiraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02)First posted July 18, 2023 · updated Oct. 14, 2026
- AvailableLiraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03)First posted July 18, 2023 · updated Oct. 14, 2026
Meitheal Pharmaceuticals, Inc.
Contact: 844-824-8426
- AvailableLiraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84)First posted July 18, 2023 · updated Aug. 27, 2026
- AvailableLiraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)First posted July 18, 2023 · updated Aug. 27, 2026
Novo Nordisk, Inc.
Contact: 833-493-4689
- AvailableLiraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20)Related information: Distributed by Teva
First posted July 18, 2023 · updated Sept. 22, 2026 - AvailableLiraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22)Related information: Distributed by Teva
First posted July 18, 2023 · updated Sept. 22, 2026 - Limited AvailabilitySaxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)Reason: Discontinuation of the manufacture of the drug
Related information: Product will be available until discontinuation in January 2027
More from FDA
First posted July 18, 2023 · updated Sept. 22, 2026 - Limited AvailabilityVictoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)Reason: Delay in shipping of the drug
Related information: Estimated shortage duration: TBD
First posted July 18, 2023 · updated Sept. 22, 2026 - Limited AvailabilityVictoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)Reason: Delay in shipping of the drug
Related information: Estimated shortage duration: TBD
First posted July 18, 2023 · updated Sept. 22, 2026
To be discontinued (2)
Novo Nordisk, Inc.
Contact: 833-493-4689
- Discontinued Aug. 25, 2026Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)Related information: Product will be available until discontinuation in January 2027; Discontinuation of the manufacture of the drug
First posted Aug. 25, 2026 · updated Aug. 25, 2026
Teva Pharmaceuticals USA, Inc.
Contact: 888-838-2872
- Discontinued May 14, 2026Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46)Related information: Discontinuation of the manufacture of the drug
First posted May 14, 2026 · updated May 14, 2026
Data provided by the U.S. Food and Drug Administration through openFDA, as of Nov. 12, 2026; FDA's drug shortage database can be newer. openFDA's own note on this data: "Do not rely on openFDA to make decisions regarding medical care." This is not medical advice: ask your pharmacist or doctor before changing or stopping a medicine.